Skip to content
ppharmaranks
Menu

REZVOGLAR vs TRADJENTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. REZVOGLAR and TRADJENTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
72/100

Pharmacy pays

Type

RX
RX

Active ingredient

INSULIN GLARGINE-AGLR
LINAGLIPTIN

Dosage forms

Injectable
Tablet

Drug class

Dipeptidyl Peptidase 4 Inhibitor

Boxed warning

None
None

Half-life

about 200 hours — the terminal (elimination) half-life at steady state, per the label

Treats

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Hyperglycemia
Type 2 Diabetes Mellitus

Get tradjentahigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

Which is better-rated, Rezvoglar or Tradjenta?

By our independent rating, Tradjenta scores higher — 3.6 vs 3.5 out of 5 for Rezvoglar. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Rezvoglar and Tradjenta?

Rezvoglar contains Insulin Glargine-Aglr, while Tradjenta contains Linagliptin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.